Skip to main
IMAX

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 42%
Buy 42%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Imax is poised for success in the near future as its Q3 earnings estimates are already significantly higher than originally projected, with a potential for even more growth in Q4 with the release of highly anticipated films such as Dune: Part Three. The success of the company's film The Odyssey, which has already generated record-breaking box office numbers, is a testament to IMAX's ability to produce immersive content experiences that audiences are eager to see. Additionally, the company's global expansion and diversification of its content slate bode well for its continued success. However, potential challenges could arise from regulations in China and a reliance on blockbuster films, which could impact box office growth in the future.

Bears say

Imax is currently overvalued based on a high multiple of 16x EV/CY27 EBITDA, and the potential risks associated with its overreliance on blockbuster titles for significant revenue. Additionally, given its heavy presence in China, which carries political risks, and the demand for its premium large format systems being driven by exhibitor partners, there could be potential challenges in maintaining stronger revenue growth in the future. Despite its current success with The Odyssey, a breakout hit based on the company's end-to-end ecosystem, this may not necessarily translate to future success with other titles.

IMAX (IMAX) has been analyzed by 12 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 42% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 12 analysts, IMAX (IMAX) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $54.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $54.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.